Precigen Exemplar Revenue and Competitors
Estimated Revenue & Valuation
- Precigen Exemplar's estimated annual revenue is currently $3.3M per year.
- Precigen Exemplar's estimated revenue per employee is $155,000
Employee Data
- Precigen Exemplar has 21 Employees.
- Precigen Exemplar grew their employee count by -25% last year.
Precigen Exemplar's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Veterinary Services | Reveal Email/Phone |
3 | Embryology and Regulatory Manager | Reveal Email/Phone |
4 | Project Manager | Reveal Email/Phone |
5 | Farm & Animal Clinical Technician II | Reveal Email/Phone |
6 | Embryologist | Reveal Email/Phone |
Precigen Exemplar Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | 83% | N/A | N/A |
#2 | $16.6M | 107 | 3% | N/A | N/A |
#3 | $1.6M | 21 | 40% | $9.1M | N/A |
#4 | $537.2M | 2166 | 6% | $31.2M | N/A |
#5 | $8.8M | 57 | 10% | N/A | N/A |
#6 | $2.8M | 18 | 38% | N/A | N/A |
#7 | $0.3M | 2 | 0% | N/A | N/A |
#8 | $0.2M | 1 | 0% | N/A | N/A |
#9 | $10.1M | 65 | 20% | N/A | N/A |
#10 | $2.2M | 28 | 40% | N/A | N/A |
What Is Precigen Exemplar?
At Precigen Exemplar , we enable discovery by providing the vehicle to break new ground on the medical research frontier. Until now, researchers have lacked animal models that faithfully represent human diseases. As a result, a sizeable barrier has blocked progress in the discovery of human disease mechanisms; novel diagnostics, procedures, devices, prevention strategies and therapeutics; and the ability to predict in humans the efficacy of those next-generation procedures, devices, and therapeutics.
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 25 | -7% | N/A |
#2 | $10.7M | 38 | 31% | N/A |
#3 | $8.4M | 39 | 11% | N/A |
#4 | $17.8M | 56 | 2% | N/A |
#5 | $34.9M | 99 | 9% | N/A |